CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2015 - 2016)
CRISPR Therapeutics AG's (CRSP) quarterly Interest & Investment Income came in at $1000.0 in Q4 2016, up 101.01% year-on-year from $497.49 in Q1 2016, and up 200.0% quarter-over-quarter from -$1000.0 in Q3 2016.
CRISPR Therapeutics AG (CRSP) Interest & Investment Income (2015 - 2016) Analysis & Trends
CRISPR Therapeutics AG has disclosed Interest & Investment Income across 2 years of filings, most recently posting $1000.0 for Q4 2016.
- Interest & Investment Income for Q4 2016 came in at $1000.0, up 101.01% year-over-year; the trailing twelve-month figure through Dec 2016 was -$8.0 million (changed N/A YoY), and the FY2016 annual result was -$8.0 million, down 7353.7% from the prior year.
- Interest & Investment Income came in at $1000.0 for Q4 2016 at CRISPR Therapeutics AG, up from -$1000.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1000.0 in Q4 2016 to a low of -$8.0 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | CRISPR Therapeutics AG | 5.21 Bn | 2.76 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 1,000.00 |
| Sep 30, 2016 | -1,000.00 |
| Mar 31, 2016 | -8.05 Mn |
| Dec 31, 2015 | -99,000.00 |
| Sep 30, 2015 | -8,000.00 |